{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:53:15Z","timestamp":1780638795813,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.radonc.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:38:20Z","timestamp":1540021100000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance"],"prefix":"10.1016","volume":"130","author":[{"given":"Jim P.","family":"Tol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Dahele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko F.A.R.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.10.005_b0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.prro.2011.11.012","article-title":"Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems","volume":"2","author":"Nelms","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0010","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1118\/1.3574874","article-title":"Knowledge-based IMRT treatment planning for prostate cancer","volume":"38","author":"Chanyavanich","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2009.07.1708","article-title":"Parotid gland function after radiotherapy: the combined michigan and utrecht experience","volume":"78","author":"Dijkema","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2007.12.033","article-title":"Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy","volume":"72","author":"Murdoch-Kinch","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijrobp.2014.11.014","article-title":"Evaluation of a knowledge-based planning solution for head and neck cancer","volume":"91","author":"Tol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13014-014-0236-0","article-title":"Assessment of a model based optimization engine for volumetric modulated arc therapy for patients with advanced hepatocellular cancer","volume":"9","author":"Fogliata","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00066-011-0006-y","article-title":"Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients","volume":"188","author":"Alongi","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2018.10.005_b0050","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1118\/1.4757927","article-title":"Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans","volume":"39","author":"Yuan","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0055","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1118\/1.4761864","article-title":"Predicting dose-volume histograms for organs-at-risk in IMRT planning","volume":"39","author":"Appenzoller","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13014-015-0542-1","article-title":"Can knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?","volume":"10","author":"Tol","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13014-015-0388-6","article-title":"Automatic interactive optimization for volumetric modulated arc therapy planning","volume":"10","author":"Tol","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.radonc.2011.05.015","article-title":"Delineation of organs at risk involved in swallowing for radiotherapy treatment planning","volume":"101","author":"Christianen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0075","doi-asserted-by":"crossref","DOI":"10.1118\/1.4862521","article-title":"Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneity","volume":"41","author":"Tol","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2017.04.019","article-title":"Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV\/p16 negative squamous cell carcinoma of the head and neck: results of the benchmark case procedure","volume":"123","author":"Christiaens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2015.01.046","article-title":"Quantifying unnecessary normal tissue complication risks due to suboptimal planning: a secondary study of RTOG 0126","volume":"92","author":"Moore","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.005_b0090","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1016\/j.ijrobp.2017.06.439","article-title":"Knowledge engineering-based quality evaluation of NRG oncology RTOG 0522 treatment plans","volume":"99","author":"Geng","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2018.03.012","article-title":"Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans","author":"Delaney","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2011.08.023","article-title":"A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT","volume":"101","author":"Stieler","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.005_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-717X-8-37","article-title":"RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison","volume":"8","author":"van Gestel","year":"2013","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T22:02:55Z","timestamp":1548540175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018335102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":21,"alternative-id":["S0167814018335102"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}